Pharmaceuticals, Biotechnology and Life Sciences
Conference Call Scheduled Today at 8:30 a.m. ET LEXINGTON, Mass.–(BUSINESS WIRE)–$CNCE #CNCE—Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results…
HENDERSON, Nev.–(BUSINESS WIRE)–Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced dosing of…
BOSTON–(BUSINESS WIRE)–AVEO Oncology (NASDAQ: AVEO) today reported financial results for the first quarter ended March 31, 2020 and provided a…
DUBLIN–(BUSINESS WIRE)–The “Cluster Headache Syndrome (Cluster Headache) – Pipeline Review, H1 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering.…
DUBLIN–(BUSINESS WIRE)–The “Acute Respiratory Distress Syndrome – Pipeline Review, H1 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. This…
Diaceutics data analytics shows 31% drop in the number of newly-diagnosed patients with lung cancer, with decrease in the number of colorectal, breast and ovarian cancers patients diagnosed, and 14% drop in newly-diagnosed patients with acute myeloid leukemia
Vertex’s product revenues of $1.52 billion, a 77% increase compared to Q1 2019, with net income reported of $602,753.
JCRI said Wednesday it is seeking approval from the Food and Drug Administration (FDA) under its Emergency Use Authorization (EUA) for using the Canady Helios Cold Plasma HERO (Humidified Electrical Reactive Oxygen) System for the treatment of patients infected with COVID-19 virus.
Genespire has secured an injection of $16M in A financing round, and also has named a new CEO, with new board members joining in.